Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Division of Clinical Decision Making and Health Care Research

University Health Network Research Institute

Toronto

Ontario

Canada

Name/email consistency: high

Division of Clinical Decision Making and Health Care Research, University Health Network Research Institute, Toronto, Ontario, Canada. 2004
Arthritis and Immune Disorder Research Centre, University Health Network, Toronto, Ontario, Canada. 2002 - 2003
University Health Network Research Institute, Toronto, Ontario, Canada. 2002 - 2003
University Health Network Research Institute, Division of Clinical Decision Making, 200 Elizabeth Street, EN6-232A, Canada. 2003
Arthritis and Autoimmunity Research Centre, Consultation and Rehabilitation Service, University Health Network, The Arthritis Society (Ontario Division), Canada. 2002

The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Maetzel, A., Li, L.C., Pencharz, J., Tomlinson, G., Bombardier, C. Ann. Rheum. Dis. (2004) [Pubmed]
Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus. Maetzel, A., Ruof, J., Covington, M., Wolf, A. Pharmacoeconomics (2003) [Pubmed]
Motion--Cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs are as safe as placebo for the stomach: arguments against the motion. Maetzel, A. Can. J. Gastroenterol. (2003) [Pubmed]
The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. Maetzel, A., Krahn, M., Naglie, G. Arthritis Rheum. (2003) [Pubmed]
Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: an evaluation based on a 1-year randomised controlled trial. Maetzel, A., Strand, V., Tugwell, P., Wells, G., Bombardier, C. Pharmacoeconomics (2002) [Pubmed]
The economic burden of low back pain: a review of studies published between 1996 and 2001. Maetzel, A., Li, L. Best. Pract. Res. Clin. Rheumatol (2002) [Pubmed]
Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Maetzel, A., Strand, V., Tugwell, P., Wells, G., Bombardier, C. Arthritis Rheum. (2002) [Pubmed]